Check out the companies making headlines before the bell. Chemours — The chemical company added about 3% after UBS upgraded the company to buy from neutral, saying the stock could outperform as refrigerants see favorable demand and price drivers heading into next year. Nvidia — Shares rose more than 1% after KeyBanc hiked its price target on the chipmaker to $180, implying upside of more than 40% from Monday’s close. “Despite the impending launch of Blackwell in 2H24, we are not seeing any signs of a demand pause as demand for H100 remains robust,” KeyBanc said. BP — The oil and gas giant’s U.S.-listed shares fell more than 4% after the company warned it expects to report an impairment of up to $2 billion. BP also sees weak margins from its refining business . Tempus AI — Shares popped nearly 4% after several Wall Street banks initiated coverage of the health-care diagnostics company with buy or overweight ratings. Tempus AI, which uses artificial intelligence to interpret medical tests, debuted on the Nasdaq in June. Intel — The chipmaker rose 2.7% in early morning trading, continuing its comeback this week. Week to date, shares are up roughly 6.1%. Helen of Troy — Shares of the Hydro Flask and Oxo parent fell more than 25% after a big earnings miss. The company earned 99 cents per share, excluding items. Analysts polled by FactSet expected a profit of $1.59 per share. Quarterly revenue guidance was also below estimates. — CNBC’s Fred Imbert and Michelle Fox Theobald contributed reporting.
